Inquiry Basket
| Catalog | Product Name | CAS Number |
|---|---|---|
| BADC-01403 | p-SCN-Bn-DOTA | 127985-74-4 |
| p-SCN-Bn-DOTA is an impurity of Gadoteridol, which is a gadolinium-based MRI contrast agent used in central nervous system imaging. | Inquiry | |
| BADC-00502 | ATFB-SE | 126695-58-7 |
| ATFB-SE is an ADC non-cleavable linker with breakthrough potential in the field of drug release carriers and targeted therapy. It can be used for biomolecule, protein and peptide labeling. | Inquiry | |
| BADC-00887 | t-Boc-N-amido-PEG4-bromide | 1076199-21-7 |
| t-Boc-N-amido-PEG3-bromide is a PEG linker containing a bromide group and a Boc-protected amino group. The hydrophilic PEG spacer increases solubility in aqueous media. The bromide (Br) is a very good leaving group for nucleophilic substitution reactions. The Boc group can be deprotected under mild acidic conditions to form the free amine. | Inquiry | |
| BADC-01974 | Nα-N3-Nε-Boc-D-lysine | 1178899-92-7 |
| Inquiry | ||
| BADC-00509 | MTS-4-NHS | 690632-55-4 |
| Inquiry | ||
| BADC-00508 | SPDPH | 158913-22-5 |
| SPDPH is a biochemical product used in cancer drug development. It acts as a linker moiety for attaching biomolecules to surfaces or to each other. The product plays a key role in drug delivery systems, cancer diagnostics and targeted therapies. SPDPH enables the targeted delivery of drugs and diagnostics, thereby increasing the efficacy and specificity of cancer treatments. | Inquiry | |
| BADC-01973 | Boc-(4S)-4-azido-D-proline dicyclohexylamine salt | 132622-77-6 |
| Inquiry | ||
| BADC-01947 | Z-AEVD-FMK | 1135688-47-9 |
| Z-AEVD-FMK is a cell-permeant and irreversible caspase-10 inhibitor. It is a cleavable ADC linker for the synthesis of antibody active molecule conjugates (ADCs). | Inquiry | |
| BADC-01590 | exo-3-Amino-9-Boc-9-azabicyclo[3.3.1]nonane | 1363380-67-9 |
| exo-3-Amino-9-Boc-9-azabicyclo[3.3.1]nonane is a precursor in drug synthesis. This compound serves as a key intermediate in the development of a variety of drugs for central nervous system diseases, including but not limited to Alzheimer's disease and Parkinson's disease. | Inquiry | |
| BADC-01916 | 20-(tert-Butoxy)-20-oxoicosanoic acid | 683239-16-9 |
| 20-(tert-Butoxy)-20-oxoicosanoic acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-01921 | tert-Butyl Hydrogen Hexadecanedioate | 843666-27-3 |
| tert-Butyl Hydrogen Hexadecanedioate is a non-cleavable ADC linker and also an alkyl chain-based PROTAC linker. | Inquiry | |
| BADC-01566 | (2S,4R)-1-((S)-17-Amino-2-(tert-butyl)-4-oxo-6,9,12,15-tetraoxa-3-azaheptadecanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide | 2010159-57-4 |
| (2S,4R)-1-((S)-17-Amino-2-(tert-butyl)-4-oxo-6,9,12,15-tetraoxa-3-azaheptadecanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide is a linker widely used in antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-01559 | 2,2-Dimethyl-4-oxo-3,8,11,14-tetraoxa-5-azahexadecan-16-yl 4-methylbenzenesulfonate | 1246999-33-6 |
| 2,2-Dimethyl-4-oxo-3,8,11,14-tetraoxa-5-azahexadecan-16-yl 4-methylbenzenesulfonate is a linker widely used in antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-00615 | JUN68744 | 1703768-74-4 |
| JUN68744 is a useful peptide linker for synthesis of PSMA-617 (vipivotide tetraxetan), which is a ligand used to make 177Lu-PSMA-617, a radioactive molecule to fight cancer. PSMA-617 originally was developed at the German Cancer Research Center and the Heidelberg University Hospital. ABX held the exclusive license to bring the treatment, which targets prostate-specific membrane antigen (PSMA), through early clinical development. | Inquiry | |
| BADC-01495 | N6-((2-azidoethoxy)carbonyl)-L-lysine | 1167421-25-1 |
| UAA crosslinker 1 act as substrates for pylRS/tRNA pair that enable its incorporation into a target protein. | Inquiry | |
| BADC-01489 | UAA crosslinker 1 hydrochloride | 1994331-17-7 |
| UAA crosslinker 1 hydrochloride is an amber codon used for non-canonical amino acids (ncAAs) incorporation. The ncAAs can be incorporated into proteins in vivo by making use of the promiscuous activity of certain wildtype and engineered aminoacyl-tRNA synthetases. | Inquiry | |
| BADC-01997 | N3-Dab(Boc)-OH | 1932403-71-8 |
| Inquiry | ||
| BADC-01985 | Nα-Azido-Nβ-Boc-L-2,3-diaminopropionic acid | 1932432-15-9 |
| Inquiry | ||
| BADC-01500 | 6-Maleimidohexanoic Acid N-Hydroxysuccinimide Ester | 55750-63-5 |
| 6-Maleimidohexanoic Acid N-Hydroxysuccinimide Ester is used for preparation of enzyme immunoconjugates and hapten carrier molecule conjugates. | Inquiry | |
| BADC-00876 | N-Boc-diethanolamine | 103898-11-9 |
| N-Boc-diethanolamine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry |
